Most read article(s)

You have access
The Pharmacological Basis of Cannabis Therapy for Epilepsy
Doodipala Samba Reddy and Victoria M. Golub

Journal of Pharmacology and Experimental Therapeutics April 2016, 357 (1) 45-55; DOI: https://doi.org/10.1124/jpet.115.230151
Open Access
SEP-363856, a Novel Psychotropic Agent with a Unique, Non-D₂ Receptor Mechanism of Action
Nina Dedic, Philip G. Jones, Seth C. Hopkins, Robert Lew, Liming Shao, John E. Campbell, Kerry L. Spear, Thomas H. Large, Una C. Campbell, Taleen Hanania, Emer Leahy and Kenneth S. Koblan

Journal of Pharmacology and Experimental Therapeutics October 2019, 371 (1) 1-14; DOI: https://doi.org/10.1124/jpet.119.260281
Open Access
Nonclinical Characterization of the Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat, a Novel Treatment of Anemia of Chronic Kidney Disease
Ughetta del Balzo, Pierre E. Signore, Gail Walkinshaw, Todd W. Seeley, Mitchell C. Brenner, Qingjian Wang, Guangjie Guo, Michael P. Arend, Lee A. Flippin, F. Aisha Chow, David C. Gervasi, Christian H. Kjaergaard, Ingrid Langsetmo, Volkmar Guenzler, David Y. Liu, Steve J. Klaus, Al Lin and Thomas B. Neff

Journal of Pharmacology and Experimental Therapeutics August 2020, 374 (2) 342-353; DOI: https://doi.org/10.1124/jpet.120.265181
You have access
Roflumilast Increases Bacterial Load and Dissemination in a Model of Pseudomononas Aeruginosa Airway Infection
Gopinath Kasetty, Praveen Papareddy, Ravi K.V. Bhongir and Arne Egesten

Journal of Pharmacology and Experimental Therapeutics April 2016, 357 (1) 66-72; DOI: https://doi.org/10.1124/jpet.115.229641
You have access
Pharmacological Characterization of AZD5069, a Slowly Reversible CXC Chemokine Receptor 2 Antagonist
David J. Nicholls, Katherine Wiley, Ian Dainty, Fraser MacIntosh, Caroline Phillips, Alasdair Gaw and Carina Kärrman Mårdh

Journal of Pharmacology and Experimental Therapeutics May 2015, 353 (2) 340-350; DOI: https://doi.org/10.1124/jpet.114.221358
Open Access
In Vitro and In Silico Characterization of Lemborexant (E2006), a Novel Dual Orexin Receptor Antagonist
Carsten Theodor Beuckmann, Michiyuki Suzuki, Takashi Ueno, Kazuya Nagaoka, Tohru Arai and Hiroyuki Higashiyama

Journal of Pharmacology and Experimental Therapeutics August 2017, 362 (2) 287-295; DOI: https://doi.org/10.1124/jpet.117.241422
Open Access
Tegoprazan, a Novel Potassium-Competitive Acid Blocker to Control Gastric Acid Secretion and Motility
Nobuyuki Takahashi and Yukinori Take

Journal of Pharmacology and Experimental Therapeutics February 2018, 364 (2) 275-286; DOI: https://doi.org/10.1124/jpet.117.244202
Open Access
Morphine Interaction with Aspirin: a Double-Blind, Crossover Trial in Healthy Volunteers
Johann Bartko, Christian Schoergenhofer, Michael Schwameis, Patricia Wadowski, Jacek Kubica, Bernd Jilma and Eva-Luise Hobl

Journal of Pharmacology and Experimental Therapeutics May 2018, 365 (2) 430-436; DOI: https://doi.org/10.1124/jpet.117.247213
Open Access
K_ATP Channel Openers Inhibit Lymphatic Contractions and Lymph Flow as a Possible Mechanism of Peripheral Edema
Brittney R. Garner, Amanda J. Stolarz, Daniel Stuckey, Mustafa Sarimollaoglu, Yunmeng Liu, Philip T. Palade, Nancy J. Rusch and Shengyu Mu

Journal of Pharmacology and Experimental Therapeutics January 2021, 376 (1) 40-50; DOI: https://doi.org/10.1124/jpet.120.000121
You have access
The Effect of Phytocannabinoids on Airway Hyper-Responsiveness, Airway Inflammation, and Cough
Raj Makwana, Radhakrishnan Venkatasamy, Domenico Spina and Clive Page

Journal of Pharmacology and Experimental Therapeutics April 2015, 353 (1) 169-180; DOI: https://doi.org/10.1124/jpet.114.221283

Main menu

User menu

Search

Most read article(s)

Pages

Navigate

More Information

ASPET's Other Journals